News Focus
News Focus
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 830

Monday, 11/04/2019 4:11:15 PM

Monday, November 04, 2019 4:11:15 PM

Post# of 9090
RVNC completes enrollment—(301 patients)—in ASPEN-1 CD efficacy trial:

https://investors.revance.com/news-releases/news-release-details/revance-completes-enrollment-aspen-1-phase-3-pivotal-trial

Top line data is expected in 2H20.

See #msg-148887973 for related info on RVNC’s CD program.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”